Brief: Island Pharmaceuticals Seeks Trading Halt
01/02/2026 21:44
Feb 2 (Reuters) - Island Pharmaceuticals ILA.AX: SEEKS TRADING HALT PENDING FDA FEEDBACK ON GALIDESIVIR PROGRAM Further company coverage: ILA.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic